Harrow (HROW) Change in Accured Expenses (2010 - 2026)

Harrow's (HROW) quarterly Change in Accured Expenses came in at $3.4 million in Q1 2026, up 278.58% year-on-year from $892011.0 in Q1 2025, and down 87.93% quarter-over-quarter from $28.0 million in Q4 2025.

Harrow (HROW) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Harrow's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 278.58% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $6.2 million, a 86.07% decrease from a year earlier, with the FY2025 full-year figure at $936000.0, down 97.5% from the prior year.
  • Change in Accured Expenses declined to $3.4 million in Q1 2026 per HROW's latest filing, from $28.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $35.8 million in Q4 2024 and bottomed at -$22.1 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is -$598000.0 (2022), against an average of $2.6 million.
  • Biggest YoY gain for Change in Accured Expenses was 27200.0% in 2024; the steepest drop was 704.59% in 2024.
  • Year by year, Change in Accured Expenses stood at -$598000.0 in 2022, then surged by 121.91% to $131000.0 in 2023, then jumped by 27200.0% to $35.8 million in 2024, then dropped by 21.75% to $28.0 million in 2025, then slumped by 87.93% to $3.4 million in 2026.
  • Per Business Quant, the three latest HROW Change in Accured Expenses figures stand at $3.4 million (Q1 2026), $28.0 million (Q4 2025), and -$3.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.86 Bn 88.00 Bn - -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.70 Bn 30.76 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.73 Bn 23.67 Bn 4.39 Bn -
5 United Therapeutics 23.16 Bn 21.01 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.18 Bn 18.37 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn -
10 Harrow 1.40 Bn 1.31 Bn 27.05 Mn 3.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.38 Mn
Mar 31, 2026 3.38 Mn
Dec 31, 2025 27.99 Mn
Dec 31, 2025 27.99 Mn
Sep 30, 2025 -3.04 Mn
Sep 30, 2025 -3.04 Mn
Jun 30, 2025 -22.12 Mn
Jun 30, 2025 -22.12 Mn
Mar 31, 2025 -1.89 Mn
Mar 31, 2025 -1.89 Mn
Dec 31, 2024 35.76 Mn
Dec 31, 2024 35.76 Mn
Sep 30, 2024 1.46 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 9.21 Mn
Jun 30, 2024 9.21 Mn
Mar 31, 2024 -8.94 Mn
Mar 31, 2024 -8.94 Mn
Dec 31, 2023 131,000.00
Dec 31, 2023 131,000.00